The Digital Musculoskeletal (MSK) Market Transformation Forecast 2026–2035
- Nelson Advisors
- 43 minutes ago
- 14 min read
Strategic Outlook: The Digital Musculoskeletal (MSK) Market Transformation (2026–2035)
The global healthcare landscape is rapidly converging upon a singular, undeniable crisis point regarding musculoskeletal (MSK) health, creating a definitive "before and after" scenario centred around the year 2026. For decades, MSK disorders, encompassing conditions ranging from non-specific low back pain (LBP) to complex post-surgical rehabilitation, have served as the silent epidemic of the industrialized world.
However, as we approach the latter half of the 2020s, the convergence of aging demographics, workforce health crises, and unsustainable surgical costs has transformed this clinical category into a primary driver of global healthcare innovation. The digital MSK market, once a niche segment of the broader telehealth revolution, is now forecasted to undergo massive, systemic growth, driven not merely by convenience but by urgent economic and clinical necessity.
The Burden of Disease and Economic Inactivity
The impetus for the massive growth forecasted for 2026 stems from the sheer scale of the MSK burden. Musculoskeletal conditions are currently the leading cause of disability worldwide, affecting over 1.7 billion people. In the United Kingdom alone, poor musculoskeletal health has emerged as a leading cause of health-related economic inactivity, with an estimated 26.5 million working days lost to these conditions in 2024. This is not merely a clinical statistic but a macroeconomic warning sign; as workforce productivity stagnates, the inability of traditional healthcare systems to manage chronic pain efficiently has become a drag on national GDPs.
In the United States, the financial stakes are even higher. MSK disorders affect approximately one in two adults, costing payers and patients an estimated $661 Billion annually.This expenditure is driven largely by a "surgical-first" culture that prioritises high-cost interventions, such as spinal fusions and joint replacements, over conservative management. Data indicates that up to 30% of MSK surgeries may be inappropriately performed and 36% of all MSK surgeries are considered unnecessary. With the average cost of a single lumbar surgery exceeding $22,000, and often ranging significantly higher depending on complications, the economic incentives for "surgery avoidance" technologies have never been stronger.
The year 2026 is projected to be a watershed moment because it marks the maturation of digital interventions that can credibly claim to reverse these trends. The market is moving beyond simple "tele-physio" video calls toward comprehensive, AI-driven platforms that integrate preventative care, acute injury management, and post-surgical rehabilitation.
By 2025, the global digital MSK care market is estimated to be valued at approximately $5.10 Billion, but this is merely the baseline. Forecasts indicate an acceleration to nearly $16 Billion by 2032, driven by compound annual growth rates (CAGR) exceeding 17%. This growth is structurally underpinned by a shift in payer mentality: insurers and self-insured employers are no longer viewing digital MSK as a "wellness perk" but as a primary mechanism for cost containment and risk management.
The "Left Shift" and Systemic Transformation
A critical driver for the 2026 growth explosion is the explicit policy objective in major health systems to move care "upstream" and "left", meaning away from hospitals and into the community or home. In the UK, the government's "10 Year Health Plan" and the NHS's strategic focus on moving "from analogue to digital" and "hospital to community" provide the regulatory tailwind for this shift. The goal is to end the "8 am scramble" for GP appointments by empowering patients to self-manage conditions via digital tools integrated into the NHS App.
This policy shift creates a fertile environment for digital MSK platforms like getUBetter, which has already achieved adoption across 40% of NHS England's Integrated Care Systems (ICSs). By enabling patients to self-manage common injuries without seeing a GP, these platforms directly alleviate the workforce crisis. With NHS community MSK waiting lists exceeding 388,000 people in August 2025, the traditional system has reached capacity. The "massive growth" predicted for 2026 is, therefore, partly a function of supply-side constraints; without digital scalability, national health systems face collapse in MSK service delivery.
Quantitative Market Architecture and Forecasts
To understand the magnitude of the opportunity in 2026 and beyond, it is essential to dissect the market sizing data, regional variances, and segmentation trends that define the sector.
Global Market Valuation and Growth Vectors
The financial projections for the digital MSK market reflect high confidence among analysts, though methodologies vary. The consensus indicates a market entering a "hyper-growth" phase.
Global Digital MSK Market Forecasts (2024–2035)
Metric | Grand View Research | Coherent Market Insights | Research and Markets | Quintile Reports |
2024/2025 Valuation | ~$4.44 Billion (2024) | ~$5.10 Billion (2025) | ~$4.53 Billion (2024) | ~$6.45 Billion (2025) |
Future Valuation | ~$11.64 Billion (2030) | ~$15.92 Billion (2032) | ~$26.54 Billion (2035) | ~$12.35 Billion (2034) |
CAGR | 17.7% (2025-2030) | 17.64% (2025-2032) | 17.43% (2025-2035) | 18.17% (2025-2034) |
Key Growth Driver | Prevalence of disorders, aging population | Telemedicine adoption, cost-effective treatment | Wearable tech, AI diagnostics | Rapid tech adoption, sustainable practices |
The data suggests a robust expansion trajectory, with the market expected to nearly triple in value between 2025 and 2032. The consistent CAGR estimates in the high teens (17-18%) across multiple independent reports reinforce the structural nature of this growth.
Regional Dominance and Emerging Pockets
While North America currently leads the market, holding approximately 40.3% of the revenue share in 2025, the dynamics are shifting. The US market is characterised by high healthcare spending and the dominance of the self-insured employer model, where companies like Hinge Health and Sword Health compete for corporate contracts to lower claims costs.
However, the Asia Pacific region is projected to be the fastest-growing market, expected to capture a 35.2% share by 2025. This rapid acceleration is fuelled by the digitalisation of healthcare infrastructure in China and India, alongside the pressing needs of Japan’s super-aged society. In Europe, the United Kingdom represents a significant growth node.
The UK digital MSK market is forecast to grow from $194.7 million in 2024 to $526.0 million by 2030, registering a CAGR of 18.2%. This growth outperforms the broader corporate wellness market in the UK, which is expected to grow at a modest 3.8% CAGR over the same period, highlighting that MSK is a specific high-value vertical within the broader health ecosystem.
Segment Analysis: Software vs. Hardware
The market is bifurcated into hardware (wearables, sensors) and software (apps, platforms). Currently, the Software & Services segment dominates, accounting for approximately 60% of revenue in 2024/2025. This dominance is driven by the scalability of app-based solutions that do not require complex logistics.
However, a divergence in forecast exists: while software remains the largest revenue generator, Hardware is identified by some analysts as the fastest-growing component over the forecast period. This is attributed to the increasing sophistication of wearable sensors and diagnostic tools that offer real-time monitoring capabilities, moving beyond simple step-counting to clinical-grade range-of-motion (ROM) analysis.
Conversely, other reports suggest that Online/Virtual Consultations will maintain dominance due to the rising accessibility of telemedicine. This tension, between hardware enabled precision and software-enabled scalability—defines the central technological battleground for 2026.
Technological Convergence: The 2026 Architecture
By 2026, the technological underpinnings of digital MSK care will have evolved from "digitised analog care" (video calls) to "digitally native care" (AI, Computer Vision, VR).
The Modality War: Sensors vs. Computer Vision
A critical strategic divide exists between providers utilizing physical sensors and those relying on computer vision (CV).
Sensor-Based Modalities:
Companies like Hinge Health have built their clinical validity on sensor-based biofeedback. By strapping wearable sensors (e.g., Enso) to the patient, these platforms track movement fidelity with high precision.
The argument for sensors is data granularity; they can detect subtle shifts in movement that a camera might miss. Hinge Health’s outcomes, including a 3.3x ROI in Medicare populations, are heavily predicated on this hardware-integrated approach. However, hardware introduces friction: devices must be shipped, charged, and paired, creating logistical barriers and higher unit economics.
Computer Vision (CV) Modalities:
Conversely, Kaia Health and Sword Health are championing computer vision. Kaia’s "Motion Coach" utilizes the user's smartphone camera to track exercise form without peripheral hardware. This "hardware-free" approach significantly lowers the barrier to entry and cost of goods sold (COGS). Crucially, clinical validation studies published in the Journal of Medical Internet Research have demonstrated that Kaia's CV technology is as accurate as physical therapists in suggesting exercise corrections.
Sword Health employs a hybrid approach but has increasingly marketed its "lens-less" sensor technology while also leveraging CV for scalability. By 2026, improvements in mobile processing power and camera fidelity will likely tip the scale toward CV solutions for general population management, reserving sensors for high-acuity post-surgical cases.
Generative AI and the "AI Therapist"
The most transformative technology arriving at maturity in 2026 is Generative AI. Beyond simple chatbots, GenAI is being integrated into the clinical pathway to automate triage, documentation, and even therapy delivery.
AI Clinics:
Flok Health has launched the first AI-powered physiotherapy clinic in England, approved by the Care Quality Commission (CQC). Using AI video generation, Flok provides "same-day appointments" via an app, where a digital avatar conducts the assessment. Trials in Cambridgeshire showed a 55% reduction in back pain waiting lists and a 44% reduction in wait times for all MSK conditions. This proves that AI can function as a capacity multiplier, freeing up human clinicians for complex cases.
Clinical Automation:
In Northamptonshire, NHS services are trialing "Magic Notes," an AI tool that listens to consultations and automatically generates clinical summaries. This reduces administrative burden, allowing physiotherapists to focus on patient care. As these tools become standard in 2026, the efficiency gains will drive higher throughput in MSK clinics.
Predictive Analytics:
Sword Health’s "Predict" engine represents the shift from reactive to proactive care. By analyzing historical claims data and member history, the AI identifies individuals at high risk of unnecessary surgery before they even consult a surgeon. Sword claims this predictive intervention can reduce surgery intent by up to 70%.
Virtual Reality (VR) and Immersive Therapeutics
VR is transitioning from a gaming technology to a reimbursed medical device. The global AR and VR healthcare market is projected to grow at a CAGR of 24.81% through 2034. In 2025, XRHealth acquired RealizedCare, creating a comprehensive platform that combines immersive VR environments with digital cognitive behavioural therapy (CBT). VR is particularly effective for chronic pain management through "distraction therapy," which re-trains the brain's pain processing pathways. By 2026, VR headsets will likely be standard equipment in pain management clinics and home-based chronic pain programs.
The Regulatory Crucible: Compliance as a Moat
The regulatory environment in 2026 will no longer be the "Wild West" of early digital health. Strict frameworks in the EU, US, and UK will act as a filter, favouring established players with the resources to navigate complex compliance landscapes.
The EU AI Act: A New Global Standard
The EU AI Act, fully applicable from August 2, 2026, represents the most significant regulatory disruption in the sector. Under this Act, AI systems used for medical triage or diagnosis are classified as "High-Risk AI Systems".
Compliance Obligations:
Quality Management Systems (QMS): Providers must implement rigorous QMS to manage risks throughout the AI lifecycle.
Data Governance: Training data must be vetted for bias to prevent discriminatory outcomes in healthcare delivery.
Conformity Assessments: High-risk systems must undergo third-party conformity assessments by notified bodies.
Penalties: Non-compliance can result in fines of up to 3% of global turnover or €15 Million.
This regulation creates a substantial "moat" for incumbents like Kaia Health and Sword Health, who have already invested in medical-grade compliance (MDR Class IIa certification). Startups lacking this infrastructure will struggle to enter the European market post-2026.
US Reimbursement: The CPT Code Revolution (2026)
In the United States, the maturation of Remote Therapeutic Monitoring (RTM) codes is aligning financial incentives with digital care delivery. The Centers for Medicare & Medicaid Services (CMS) have proposed critical updates for the 2026 Physician Fee Schedule that directly address previous limitations.
2026 US CPT Code Landscape for Digital MSK
CPT Code | Description | 2026 Status/Change | Strategic Implication |
98977 | RTM Device Supply (MSK System) | Revised (16-30 days) | Reimbursement ~$40-47. Continues to support chronic care monitoring requiring steady data streams. |
98985 | RTM Device Supply (Short-term) | NEW (2-15 days) | Game Changer: Allows providers to bill for short acute episodes (e.g., rapid post-op recovery) where 16 days of data is unnecessary. Reimbursement ~$40.24 |
98980 | RTM Treatment Mgmt (First 20 min) | Active | Reimbursement ~$54. Covers clinician time reviewing AI-generated data insights. |
98979 | RTM Treatment Mgmt (Short-term) | NEW (First 10 min) | Flexibility: Allows reimbursement for shorter check-ins (10-19 mins), acknowledging that efficient digital tools reduce required interaction time.24 |
98975 | Initial Setup & Education | Active | Reimbursement ~$21. Covers the cost of onboarding patients to the app/device. |
The introduction of codes 98985 and 98979 solves a critical misalignment. Previously, if a patient recovered quickly (in less than 16 days), the provider lost revenue because they couldn't bill the device code. The new codes incentivise efficiency, rewarding providers for rapid recoveries—a perfect fit for effective digital MSK interventions.
UK Frameworks: DTAC and the NHS App
In the UK, the Digital Technology Assessment Criteria (DTAC) is the non-negotiable gateway for NHS adoption. It evaluates clinical safety, data protection, technical security, interoperability, and usability.
Clinical Safety: Apps must employ a Clinical Safety Officer and demonstrate risk management.
Integration: Successful platforms like getUBetter have integrated directly into the NHS App, allowing patients to access prescribed digital therapeutics via their primary health interface.The NHS App is transitioning to a "digital front door," where patients can self-refer to MSK services, view care plans, and book appointments.
Interoperability: The focus on the Federated Data Platform means apps must be able to write data back to the patient's record, moving beyond siloed ecosystems.
Clinical Validity and the ROI Landscape
As the market matures, the sales pitch has shifted from "employee wellness" to "hard dollar ROI." Claims reduction is the primary metric for 2026.
The ROI Battleground: Hinge vs. Sword
The two market leaders, Hinge Health and Sword Health, are engaged in a fierce battle to prove superior economic outcomes.
Hinge Health:
Hinge's validity rests on its massive scale. A claims-based study across 136 employers demonstrated a 2.4x ROI. The study compared members to a control group and found a $2,387 reduction in MSK medical claims per participant in the first year.
Drivers of Savings: The primary driver was a 39% reduction in surgery-related claims. Savings were also realised in reduced imaging and injections.
Medicare Impact: In a separate study of older adults, Hinge demonstrated an even higher 3.3x ROI($3,289 savings per member), proving efficacy in complex, age-related conditions.
Sword Health:
Sword Health counters with a higher claimed ROI of 3.2x ($3,177 savings per member), a figure they state is "independently validated" by Risk Strategies Consulting.
Business Model Innovation: Sword has pioneered 100% risk-based pricing. They only charge fees if the patient achieves defined clinical outcomes. This puts their revenue at risk but signals extreme confidence in their product.
Comparison: Sword explicitly markets against Hinge, claiming their "Digital Physical Therapist" (vs. Hinge's health coaches) leads to better outcomes and that Hinge's ROI is lower.
Omada Health:
Omada, primarily known for metabolic health, has entered the MSK space with a focus on "Joint & Muscle Health." Their data shows a 1.8x ROI and median savings of over $1,000 per member.33 While their ROI multiple is lower, their advantage lies in the "whole person" platform, managing diabetes and MSK co-morbidities simultaneously.
Clinical Outcomes vs. Economic Necessity
The data indicates that "surgery avoidance" is the single most valuable metric. With spinal fusions and joint replacements costing tens of thousands of dollars, preventing even a small fraction of these procedures justifies the cost of the entire digital program. Sword Health’s "Predict" engine specifically targets this by identifying "high-risk" members, those likely to spiral into surgery and intervening with aggressive conservative care.
Payer and Corporate Adoption Strategies
The buyer landscape has evolved from experimental pilots to strategic, wide-scale deployments.
Corporate Wellness and "Point Solution Fatigue"
Employers are overwhelmed by the number of digital health apps. This "point solution fatigue" is driving consolidation. In 2026, standalone MSK apps will increasingly be purchased through aggregators like Personify Health (formerly Virgin Pulse) or Wellhub.
Travis Perkins Case Study: This UK construction giant (20,000+ colleagues) integrated digital wellbeing tools alongside a network of 250+ Mental Health First Aiders. Their approach highlights the need for apps to sit within a broader ecosystem of support, including Employee Assistance Programs (EAPs) and financial wellbeing tools.
Barclays Case Study: Legal pressures are also driving adoption. A tribunal ruling against Barclays regarding "reasonable adjustments" for an employee with a chronic condition underscores the legal risk of failing to support employee health. Digital tools provide a scalable, auditable way to demonstrate support for chronic MSK conditions in the workplace.
The Insurance Sector: From Payer to Partner
Insurers are shifting from passively paying claims to actively managing health via tech partnerships.
Vitality Health & Google:
Vitality has partnered with Google Cloud to launch "Vitality AI." This platform uses Google's Gemini models to analyse member data (health, lifestyle, clinical risk) and generate hyper-personalised recommendations.
Goal: To extend healthy life expectancy and reduce claims. Vitality data shows that personalised screening can increase cancer detection rates by 19%. This partnership signals that Big Tech (Google) views the insurance layer as the ideal distribution channel for its health AI.
UK Private Medical Insurance (PMI):
Aviva: Offers a "BacktoBetter" pathway that allows members to access MSK case management without a GP referral. Members can use the Aviva Digital GP app to get a referral to a physiotherapist, bypassing NHS waiting lists entirely.
AXA vs. Bupa: Both major insurers have integrated digital GP services (AXA's "Doctor at Hand" vs. Bupa's "Digital GP"). However, they differentiate on coverage nuances. AXA is noted for flexible outpatient options and keen pricing, while Bupa offers extensive network access and comprehensive cancer cover. Both utilise digital triage to steer patients toward the most cost-effective care pathway, often digital physio.
Workforce Transformation: The Physiotherapy Crisis
The "massive growth" of digital MSK is also a response to a breaking point in the human workforce.
The Supply-Demand Mismatch
The UK is facing a severe shortage of physiotherapists. The Chartered Society of Physiotherapy (CSP) reports that 74% of NHS physiotherapists have experienced a decline in the quality of rehabilitation they can offer due to lack of space and resources. NHS waiting lists for MSK care are rising month-on-month.
TechUK's Assessment: A survey of digital health professionals found that 96% believe workforce pressures are preventing digital progress, yet 60% feel unprepared to deliver on the NHS's digital ambitions.
Digital as the Only Viable Solution
In this context, digital platforms are not "replacing" physios but "saving" the service.
Capacity Release: Platforms like getUBetter reduce GP follow-up appointments by 13% and physiotherapy referrals by 20%. This "releases" human capacity to focus on complex patients who genuinely need hands-on care.
Hybrid Workforce: The future workforce will be hybrid. The CSP is advocating for "clinical informaticians" and digital leadership roles within physiotherapy. By 2026, a physiotherapist's job description will include managing a "digital caseload" of patients monitored via AI, alongside their in-person clinic list.
Strategic Conclusion
As we look toward 2026 and beyond, the Digital MSK market is not merely "growing"; it is becoming the structural foundation of modern orthopedic care. The convergence is complete: Generative AI provides the intelligence, Computer Vision provides the accessibility, New CPT Codes provide the financial incentive, and the EU AI Act provides the safety guardrails.
The winners in this new era will be the platforms that can seamlessly integrate into the "phygital" workflow, triaging patients via an app, treating the 50-70% of simple cases digitally, and intelligently routing complex cases to human surgeons and therapists.
For employers and payers, the question is no longer "Should we offer digital MSK?" but "Which partner offers the most rigorous, risk-adjusted ROI?" In a world of rising costs and aging populations, digital MSK has graduated from a novelty to a necessity.
Nelson Advisors > MedTech and HealthTech M&A
Nelson Advisors specialise in mergers, acquisitions and partnerships for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk
Nelson Advisors regularly publish Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital
We share our views on the latest Healthcare Technology mergers, acquisitions and partnerships with insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb
Founders for Founders > We pride ourselves on our DNA as ‘HealthTech entrepreneurs advising HealthTech entrepreneurs.’ Nelson Advisors partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk
#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #BuySide #SellSide#Divestitures #Corporate #Portfolio #Optimisation #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising#BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech
Nelson Advisors LLP
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Meet Us @ HealthTech events
October 2025
Healthcare Summit 2025, London, UK – Chairing the HealthTech M&A Panel
Healthcare Summit 2025, London, UK – Chairing the HealthTech Deal Structuring Panel
NHS Clinical Entrepreneur Conference, Belfast, Northern Ireland
Global Health Exhibition 2025, Riyadh, Saudi Arabia – Chairing the HealthTech M&A Panel
November 2025
HealthTech X Summit, London, UK – Chairing the “HealthTech predictions for 2026” Panel
MedTech Europe 2025, Valletta, Malta- Speaker on the "Startups, Corporates & Hospitals: How to Build Meaningful MedTech Partnerships" panel
MedTech Europe 2025, Valletta, Malta- Judge for the MedTech StartUp Pitch Awards
Leaders in Health Summit 2025
December 2025
HealthTech Forward 2025, Barcelona, Spain – Moderating the Health Data Under Attack” Panel
Healthcare Club, IESE Business School, Barcelona, Spain
HealthInvestor Power List Awards 2025, London, UK – Judging Panel
